The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
Scientists from James Cook University have developed a new computer tool that reveals layers of gene activity that were ...
The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.
The company also announced it has initiated AGLOW, a Phase 2 proof-of-concept study of VX-407 for the treatment of ADPKD. VX-407 is an ...